Preparation for diagnosis of the metabolic syndrome and diseases including the syndrome
US6410339B1 · kind B1 · utility
11Cited by
0References
13Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Feb 26, 1998 |
| Grant date | Jun 25, 2002 |
| Priority date | — |
| Expiry date | Feb 26, 2018 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N33/743
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The use of cortisol agonist for preparing a system for diagnosis of the Metabolic Syndrome and related conditions as belly fatness, insulin resistance including increased risk of developing senile diabetes, i.e., diabetes type II, high blood fats and high blood pressure, in which system the dose of cortisol agonist is in an interval where a difference is obtained in the inhibitory effect of the autoproduction of cortisol in individuals suffering from the Metabolic Syndrome, compared to normal values.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.